Predicting human pharmacokinetics from preclinical data: clearance.

IF 1.1 Q4 PHARMACOLOGY & PHARMACY Translational and Clinical Pharmacology Pub Date : 2021-06-01 Epub Date: 2021-06-22 DOI:10.12793/tcp.2021.29.e12
Dong-Seok Yim, Soo Hyeon Bae, Suein Choi
{"title":"Predicting human pharmacokinetics from preclinical data: clearance.","authors":"Dong-Seok Yim,&nbsp;Soo Hyeon Bae,&nbsp;Suein Choi","doi":"10.12793/tcp.2021.29.e12","DOIUrl":null,"url":null,"abstract":"<p><p>We have streamlined known <i>in vitro</i> methods used to predict the clearance (CL) of small molecules in humans in this tutorial. There have been many publications on <i>in vitro</i> methods that are used at different steps of human CL prediction. The steps from initial intrinsic CL measurement <i>in vitro</i> to the final application of the well-stirred model to obtain predicted hepatic CL (CL<sub>H</sub>) are somewhat complicated. Except for the experts on drug metabolism and PBPK, many drug development scientists found it hard to figure out the entire picture of human CL prediction. To help readers overcome this barrier, we introduce each method briefly and demonstrate its usage in the chain of related equations destined to the CL<sub>H</sub>. Despite efforts in the laboratory steps, huge <i>in vitro</i> (predicted CL<sub>H</sub>)-<i>in vivo</i> (observed CL<sub>H</sub>) discrepancy is not rare. A simple remedy to this discrepancy is to correct human predicted CL<sub>H</sub> using the ratio of <i>in vitro-in vivo</i> CL<sub>H</sub> obtained from animal species.</p>","PeriodicalId":23288,"journal":{"name":"Translational and Clinical Pharmacology","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/31/26/tcp-29-78.PMC8255549.pdf","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational and Clinical Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12793/tcp.2021.29.e12","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/6/22 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 5

Abstract

We have streamlined known in vitro methods used to predict the clearance (CL) of small molecules in humans in this tutorial. There have been many publications on in vitro methods that are used at different steps of human CL prediction. The steps from initial intrinsic CL measurement in vitro to the final application of the well-stirred model to obtain predicted hepatic CL (CLH) are somewhat complicated. Except for the experts on drug metabolism and PBPK, many drug development scientists found it hard to figure out the entire picture of human CL prediction. To help readers overcome this barrier, we introduce each method briefly and demonstrate its usage in the chain of related equations destined to the CLH. Despite efforts in the laboratory steps, huge in vitro (predicted CLH)-in vivo (observed CLH) discrepancy is not rare. A simple remedy to this discrepancy is to correct human predicted CLH using the ratio of in vitro-in vivo CLH obtained from animal species.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
从临床前数据预测人体药代动力学:清除。
在本教程中,我们简化了已知的体外方法,用于预测人体内小分子的清除(CL)。已经有许多关于体外方法的出版物,用于人类CL预测的不同步骤。从最初的体外固有CL测量到最终应用搅拌良好的模型来获得预测的肝脏CL (CLH)的步骤有些复杂。除了药物代谢和PBPK方面的专家外,许多药物开发科学家发现很难弄清楚人类CL预测的全貌。为了帮助读者克服这一障碍,我们简要介绍了每种方法,并演示了它们在CLH相关方程链中的用法。尽管在实验室的步骤努力,巨大的体外(预测CLH)体内(观察CLH)差异并不罕见。对这种差异的一种简单补救方法是使用从动物物种中获得的体内外CLH的比率来纠正人类预测的CLH。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Translational and Clinical Pharmacology
Translational and Clinical Pharmacology Medicine-Pharmacology (medical)
CiteScore
1.60
自引率
11.10%
发文量
17
期刊介绍: Translational and Clinical Pharmacology (Transl Clin Pharmacol, TCP) is the official journal of the Korean Society for Clinical Pharmacology and Therapeutics (KSCPT). TCP is an interdisciplinary journal devoted to the dissemination of knowledge relating to all aspects of translational and clinical pharmacology. The categories for publication include pharmacokinetics (PK) and drug disposition, drug metabolism, pharmacodynamics (PD), clinical trials and design issues, pharmacogenomics and pharmacogenetics, pharmacometrics, pharmacoepidemiology, pharmacovigilence, and human pharmacology. Studies involving animal models, pharmacological characterization, and clinical trials are appropriate for consideration.
期刊最新文献
Development of in-silico drug cardiac toxicity evaluation system with consideration of inter-individual variability. Enhancing drug administration flexibility: evaluation of pharmacokinetic properties of tegoprazan orally disintegrating tablet (ODT) administered via nasogastric tube or oral dosing. Pharmacokinetics and bioequivalence study of candesartan cilexetil tablet in Chinese volunteers under fasting condition: an open-label, randomized-sequence, 2-period crossover study. Data science through natural language with ChatGPT's Code Interpreter. Emerging and upcoming therapies in insomnia.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1